Shares of General Motors were down slightly after Ford said its first-quarter profit would be lower than expected. » Read More
By: John Harwood
As they scramble for "yes" votes on their health-care plan, House leaders have a nightmare scenario in mind. » Read More
By: George Manessis
Using hedge fund analytics tool Kensho, CNBC ran a screen to see which financial companies tended to rebound after a drop like this week's. » Read More
By: Evelyn Cheng
Investor sentiment jumped to a 16-year high in Q1, according to the Wells Fargo/Gallup Investor and Retirement Optimism Index. » Read More
Goldman Sachs says its "High Sharpe Ratio" strategy beat the S&P 500 by 7 percentage points per year since 1999.
Jim Cramer clarifies why it's not time to sell Chinese stocks as the rhetoric between Donald Trump and China heats up.
Jim Cramer says U.S. companies that do business in China may need to sacrifice earnings under Trump.
The only expected major news event is Bank of Japan's monetary policy meeting, scheduled to conclude ahead of Tuesday's U.S. trading session.
The "Fast Money" traders look at different housing and homebuilding stocks that they think are building up for a strong 2017.
Jim Cramer chronicles the stunning decline in department stores and what it means for the future.
Jim Cramer expects analyst upgrades to potentially drive the market until the end of the year.
Conventional wisdom is the market rally may lose steam in the beginning of 2017, but that consensus could be wrong, one expert says.
The postelection inflow is one and half times that of all 2015, David Santschi, chief executive officer at TrimTabs, said in a release.
These are the stocks posting the largest moves after the bell on Monday: Biogen, Walt Disney Company and more.
One technician is betting that Nike will continue to disappoint following its earnings report this week.
Technology has been the best performing sector of IPO market, but over 100 highly valued big tech names have sat dormant for several years.
Financial stocks are going to continue to soar thanks to an improving economy, less regulation and higher interest rates, experts said.
Failure shouldn't have spelled career disaster.
More rate hikes may be bad news for gold, but one trader has an unusual way to make money off the yellow metal.
Shares of Kosmos Energy soared more than 11 percent Monday in afternoon trade.
Clovis Oncology shares jumped 15 percent Monday after the FDA approved Rubraca (rucaparib), the company's advanced ovarian cancer drug.
Cramer says he didn't understand Eisman's assessment that Donald Trump's administration will repeal parts of Dodd-Frank.
Jim Cramer thinks the Dow 20,000 is silly, but if the market's going to get there, it could do so on the backs of these stocks.
Jim Cramer broke down why the department store stocks are missing out on holiday cheer.
Get the best of CNBC in your inbox